NuVision Biotherapies raises £4.8M in funding to expand operations and development efforts, led by Midlands Engine Investment Fund II.
Amount Raised
£4.8 Million
Round Type
Venture
NottinghamManufacturingBiotechnologyHealth CareMedical DeviceInvestors
Description
NuVision Biotherapies, a Nottingham-based tissue-therapy company, raised £4.8M in funding. The round was led by Midlands Engine Investment Fund II, with participation from the University of Nottingham and Pioneer Group. The company aims to enhance operations and development efforts. NuVision provides innovative solutions for eye conditions through its patented Tereo Process.
Quick answer
NuVision Biotherapies raised £4.8 Million in a funding round, dated February 5, 2026. Investors: Pioneer Group, University Of Nottingham and Midlands Engine Investment Fund II. NuVision Biotherapies is based in Nottingham, England, United Kingdom.
- How much did NuVision Biotherapies raise?
- NuVision Biotherapies raised £4.8 Million in a funding round on February 5, 2026.
- Who invested in NuVision Biotherapies?
- Pioneer Group, University Of Nottingham and Midlands Engine Investment Fund II are named as investors in this round.
- What does NuVision Biotherapies do?
- NuVisio® is a biotechnology research and development spin out company from the University of Nottingham.
- Where is NuVision Biotherapies based and how big is it?
- NuVision Biotherapies is based in Nottingham, England, United Kingdom. Fundz records about 24 employees.
- Who are the decision-makers at NuVision Biotherapies?
- Fundz holds 1 contact at NuVision Biotherapies, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Device and Manufacturing around the same time
Companies in the same sectors as NuVision Biotherapies that raised within 45 days of this round, from Fundz verified event records.
- XCath raised $30M (Series C) on March 12, 2026.
- Monteris Medical raised $28M (Series E) on March 12, 2026.
- Tenon Medical raised $4.3M on March 11, 2026.
- Blue Arbor Technologies raised $5M (Series A) on February 26, 2026.
- Clee Medical raised an undisclosed amount (Seed) on February 25, 2026.
- EMED Technologies raised $8M on February 25, 2026.
Who to call at NuVision Biotherapies, and when
A new round usually means NuVision Biotherapies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NuVision Biotherapies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NuVision Biotherapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NuVision Biotherapies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NuVision Biotherapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NuVision Biotherapies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.